维普中文期刊产品整合服务
20篇 您的检索式:作者名="Pezaro"
    题名 作者 年代 出处 被引量
1Prostate cancer: measuring PSA 显示文摘Pezaro C Woo HI-I Davis ID 2014Intern Med J2014,44,5:1
2Prostate eaneer : measuring PSA显示文摘Pezaro C Woe HH Davis ID 2014Intern Med J2014,44,5:1
3Abiraterone acetate: Redefining hormone treatment for advanced prostatecancer显示文摘PEZARO C J MUKHERJI D BONO J S D 2012Drug Discov Today2012,17,56:1
4Abiraterone ac- etate:Redefining hormone treatment for advanced pros- tate cancer显示文摘Pezaro C J Mukherji D Bono J S D 2012Drug Discov Today2012,17,56:1
5Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy显示文摘Omlin A Pezaro C Gillessen SS 2014Ther Adv Urol2014,6,1:1
6Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone : clinical evidence for cross-resistance 显示文摘Mezynski J Pezaro C Bianchini D 2012Ann Oncol2012,23,11:1
7Abiraterone acetate:Redefining hormone treatment for advanced prostatecancer显示文摘Pezaro C J Mukherji D Bono JS D 2012Drug Discov Today2012,17,56:1
8New treatment developments applied to elderly patients with advanced prostate cancer显示文摘Mukherji D Pezaro CJ Shamseddine A 2013Cancer Treat Rev2013,39,6:1
9Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy显示文摘Omlin A Pezaro C Sommer S G 2014Ther Adv Urol2014,6,1:1
10Antitumour activity of abi- raterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer 显示文摘Omlin A J Pezaro C Zaidi S 2013Br J Cancer2013,3,:1
11Antitumour activity of abi- raterone and diethylstilhoestrol when administered sequentially to men with castration-resistant prostate cancer 显示文摘Omlin A J Pezaro C Zaidi S 2013Br J Cancer2013,3,:1
12First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer 显示文摘Bianchini D Omlin A Pezaro C 2013Br J Cancer2013,109,10:1
13Prostate cancer:measuring PSA显示文摘Pezaro C Woo HH Davis ID 2014Intern Med J2014,44,5:1
14Activity of cabazi- taxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents 显示文摘Pezaro C J Omlin A G Amelia A 2014Eur Urol2014,66,3:1
15Inline measurements:a native measurement technique for IPv6 networks显示文摘Pezaros D Hutchison D Gardner R D 2004INCC2004,105,10:1
16Low-overhead end-to-end Performance Measurement for Next Generation Networks 显示文摘Pezaros D Hoerdt M Hutchison D 2011IEEE Transactions on Network and Service Management2011,8,1:1
17Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms显示文摘AURELIUS OMLIN CARMEL PEZARO DEBORAH MUKHER- JI 2013Eur Urol2013,64,2:1
18Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents显示文摘PEZARO C J OMLIN A G ALTAVILLA A 2013Eur Urol2013,03,0228:1
19Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy显示文摘OMLIN A PEZARO C GILLESSEN SOMMER S 2014Ther Adv Urol2014,6,1:1
20Visceral Disease in Castration-resistant Prostate Cancer显示文摘Carmel J. Pezaro Aurelius Omlin David Lorente Daniel Nava Rodrigues Roberta Ferraldeschi Diletta Bianchini Deborah Mukherji Ruth Riisnaes Amelia Altavilla Mateus Crespo Nina Tunariu Johann S. de Bono Gerhardt Attard 2013European Urology2013,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费